A detailed history of Thompson Siegel & Walmsley LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 9,550 shares of XBI stock, worth $858,449. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,550
Previous 9,550 -0.0%
Holding current value
$858,449
Previous $885,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$82.22 - $94.12 $2,055 - $2,353
-25 Reduced 0.26%
9,550 $885,000
Q4 2022

Feb 10, 2023

BUY
$76.72 - $85.66 $734,594 - $820,194
9,575 New
9,575 $794,000
Q2 2021

Aug 09, 2021

BUY
$122.48 - $139.69 $122,480 - $139,690
1,000 Added 11.66%
9,575 $1.3 Million
Q1 2021

May 07, 2021

BUY
$129.36 - $173.99 $979,902 - $1.32 Million
7,575 Added 757.5%
8,575 $1.16 Million
Q4 2020

Feb 08, 2021

BUY
$110.36 - $151.14 $108,704 - $148,872
985 Added 6566.67%
1,000 $141,000
Q2 2020

Aug 11, 2020

BUY
$73.26 - $114.17 $1,098 - $1,712
15 New
15 $2,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.